Kelly K. Bree

Updated European Association of Urology (EAU) Prognostic Factor Risk Groups Overestimate the Risk of Progression in Patients with Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin

Niyati Lobo, Patrick J. Hensley, Kelly K. Bree et al. · European Urology Oncology · 2021 · 70 citations · Full text

Urological Research, Urology, Bacillus Calmette-guérin +11

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

Kelly K. Bree, Yong Shan, Patrick J. Hensley et al. · JAMA Network Open · 2022 · 48 citations · Full text

Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

Roberto Contieri, Patrick J. Hensley, Wei Shen Tan et al. · European Urology Oncology · 2023 · 35 citations

Oncological Outcomes, Urological Research, Urology +7

Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer

Wei Shen Tan, Ian M. McElree, Facundo Davaro et al. · European Urology Oncology · 2023 · 34 citations

Urological Research, Urology, Genitourinary Cancer +5

Robotic partial nephrectomy for clinical T2a renal mass is associated with improved trifecta outcome compared to open partial nephrectomy: a single surgeon comparative analysis

Fady Ghali, Amr A. Elbakry, Zachary Hamilton et al. · World Journal of Urology · 2019 · 28 citations

Laparoscopy, Urology, Improved Trifecta Outcome +8